{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:46:49Z","timestamp":1792090009628,"version":"4.4.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00520-026-11256-y","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:27:23Z","timestamp":1790616443000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Renal risk differences between diffuse large B-cell lymphoma and chronic lymphocytic leukemia\/small lymphocytic lymphoma: implications for supportive oncology care"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3427-4785","authenticated-orcid":false,"given":"Syed E.","family":"Pasha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumon","family":"Khalique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakahn","family":"Haddadin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Mazharuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre N.","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"issue":"6","key":"11256_CR1","first-page":"443","volume":"66","author":"LR Teras","year":"2016","unstructured":"Teras LR, DeSantis CE, Cerhan JR, Morton LM, Jemal A, Flowers CR (2016) 2016 US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin 66(6):443\u2013459","journal-title":"CA Cancer J Clin"},{"issue":"10129","key":"11256_CR2","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/S0140-6736(18)30422-7","volume":"391","author":"M Hallek","year":"2018","unstructured":"Hallek M, Shanafelt TD, Eichhorst B (2018) Chronic lymphocytic leukaemia. Lancet 391(10129):1524\u20131537","journal-title":"Lancet"},{"issue":"18","key":"11256_CR3","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1056\/NEJMra1613984","volume":"376","author":"MH Rosner","year":"2017","unstructured":"Rosner MH, Perazella MA (2017) Acute kidney injury in patients with cancer. N Engl J Med 376(18):1770\u20131781","journal-title":"N Engl J Med"},{"issue":"2","key":"11256_CR4","first-page":"395","volume":"35","author":"M Darmon","year":"2021","unstructured":"Darmon M, Vincent F, Canet E et al (2021) Acute kidney injury in critically ill patients with hematological malignancies. Leukemia 35(2):395\u2013407","journal-title":"Leukemia"},{"issue":"19","key":"11256_CR5","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1056\/NEJMra0904569","volume":"364","author":"SC Howard","year":"2011","unstructured":"Howard SC, Jones DP, Pui CH (2011) The tumor lysis syndrome. N Engl J Med 364(19):1844\u20131854","journal-title":"N Engl J Med"},{"issue":"20","key":"11256_CR6","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1002\/cncr.29566","volume":"121","author":"PA Thompson","year":"2015","unstructured":"Thompson PA, O\u2019Brien SM, Wierda WG et al (2015) Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens. Cancer 121(20):3612\u20133621","journal-title":"Cancer"},{"issue":"17","key":"11256_CR7","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1182\/blood.2021013242","volume":"138","author":"N Leung","year":"2021","unstructured":"Leung N, Nasr SH, Sethi S (2021) How I treat renal complications in multiple myeloma and other monoclonal gammopathies. Blood 138(17):1516\u20131523","journal-title":"Blood"},{"issue":"2","key":"11256_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055870","volume":"8","author":"E Canet","year":"2013","unstructured":"Canet E, Zafrani L, Lambert J et al (2013) Acute kidney injury in patients with newly diagnosed high-grade hematological malignancies: impact on remission and survival. PLoS One 8(2):e55870","journal-title":"PLoS One"},{"issue":"5","key":"11256_CR9","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/j.ajkd.2021.08.016","volume":"79","author":"MA Perazella","year":"2022","unstructured":"Perazella MA, Rosner MH (2022) Onco-nephrology: core curriculum 2022. Am J Kidney Dis 79(5):737\u2013750","journal-title":"Am J Kidney Dis"},{"issue":"9596","key":"11256_CR10","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370(9596):1453\u20131457","journal-title":"Lancet"},{"issue":"3","key":"11256_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC (2011) An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res 46(3):399\u2013424","journal-title":"Multivar Behav Res"},{"issue":"1","key":"11256_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2141.2004.05094.x","volume":"127","author":"MS Cairo","year":"2004","unstructured":"Cairo MS, Bishop M (2004) Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol 127(1):3\u201311","journal-title":"Br J Haematol"},{"issue":"11","key":"11256_CR13","first-page":"1913","volume":"11","author":"S Hingorani","year":"2016","unstructured":"Hingorani S, Guthrie KA, Batchelder A et al (2016) Acute kidney injury in hematopoietic cell transplant recipients. Clin J Am Soc Nephrol 11(11):1913\u20131922","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"11256_CR14","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3324\/haematol.2017.182907","volume":"103","author":"AR Mato","year":"2018","unstructured":"Mato AR, Nabhan C, Thompson MC et al (2018) Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis. Haematologica 103(5):874\u2013879","journal-title":"Haematologica"},{"key":"11256_CR15","first-page":"229","volume":"153","author":"E Kastritis","year":"2007","unstructured":"Kastritis E, Dimopoulos MA (2007) Renal involvement in monoclonal gammopathies. Contrib Nephrol 153:229\u2013239","journal-title":"Contrib Nephrol"},{"issue":"1","key":"11256_CR16","first-page":"47","volume":"71","author":"MH Rosner","year":"2021","unstructured":"Rosner MH, Jhaveri KD, McMahon BA, Perazella MA (2021) Onconephrology: the intersections between the kidney and cancer. CA Cancer J Clin 71(1):47\u201377","journal-title":"CA Cancer J Clin"},{"issue":"26","key":"11256_CR17","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1056\/NEJMoa1812836","volume":"379","author":"JA Woyach","year":"2018","unstructured":"Woyach JA, Ruppert AS, Heerema NA et al (2018) Ibrutinib regimens versus chemoimmunotherapy in older patients with untreated CLL. N Engl J Med 379(26):2517\u20132528","journal-title":"N Engl J Med"},{"key":"11256_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/CCI.17.00067","volume":"2","author":"U Topaloglu","year":"2018","unstructured":"Topaloglu U, Palchuk MB (2018) Using a federated network of real-world data to optimize clinical trials operations. JCO Clin Cancer Inform 2:1\u201310","journal-title":"JCO Clin Cancer Inform"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11256-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11256-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11256-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:49:06Z","timestamp":1792086546000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11256-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["11256"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11256-y","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research activity was determined to be exempt or excluded from Institutional Review Board (IRB) oversight in accordance with current regulations and institutional policy (HCA Healthcare internal reference number 2025-647), consistent with its exclusive use of de-identified, aggregated data from the TriNetX Global Collaborative Network without direct patient contact or intervention.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable\u2014this study used only de-identified, aggregated data and did not involve direct interaction with individual participants.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable\u2014no individual person\u2019s data are presented in this manuscript.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1029"}}